• About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • BRAVATO
    • Translations
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
Menu
  • About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • BRAVATO
    • Translations
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
ebola
JOIN
Posted on April 25, 2022August 3, 2023

ACIP Meeting Report – April 20th 2022

The ACIP met on April 20th to consider recommendations for a 2nd booster dose of mRNA COVID-19 vaccines. To download the CDC AC...
Read More
Posted on April 13, 2022August 3, 2023

Science News Piece on Vaccine Safety (GVDN, INSIS)

Science posted an article on April 12th titled” Pandemic propels global effort to study rare vaccine side effects”. The articl...
Read More
Posted on April 8, 2022August 3, 2023

Vaccines and Related Biological Products Advisory Committee Meeting Report April 6th

The Vaccines and Related Biological Products Advisory Committee (VRBPAC) met on April 6, 2022 to discuss considerations for COVID-...
Read More
Posted on March 24, 2022August 3, 2023

Major Publications from the WHO Global Vaccine Safety Summit

Just prior to the COVID-19 pandemic on December 2-3, 2019, the WHO Global Vaccine Safety Summit was held to celebrate the 20 yea...
Read More
Posted on February 9, 2022August 3, 2023

ACIP Meeting Report – Feb 4th 2022

Following the FDA approval of Moderna COVID-19 vaccine (Spikevax) for individuals 18 years and older on 31JAN2022, ACIP met today...
Read More
Posted on January 11, 2022August 3, 2023

Dec 6th Webinar – Unmasking Safety Signals in an Infodemic

Please find a link to published recording and presentations of the ‘Unmasking safety signals in an infodemic’ webinar held on...
Read More
Posted on January 6, 2022August 3, 2023

ACIP Meeting Report – Jan 5th 2022

Following the FDA update on the Emergency Use Authorization (EUA) Fact Sheet for Pfizer-BioNTech COVID-19 vaccine on January 3rd 2...
Read More
Posted on August 31, 2021August 3, 2023

Guidance for CEPI Developers

This SPEAC deliverable summarizes Brighton Collaboration guidance on the collection, interpretation analysis and presentation of s...
Read More
Posted on August 31, 2021August 3, 2023

Preliminary guidance on safety data collection for COVID-19 vaccine safety

This deliverable provides guidance on the collection of safety data for COVID-19 vaccine candidates. This includes a brief discuss...
Read More
Posted on June 18, 2021August 3, 2023

Draft List of Core COVID-9 AESIs for Safety Monitoring in LMICs

As global distribution of COVID-19 vaccine expands, the Brighton Collaboration has identified a subset of adverse events of specia...
Read More
Previous page 1 2 3 Next page

Recent Posts

  • Brighton Collaboration News — Summer 2026August 31, 2026
  • Fetal VacciniaAugust 10, 2026
  • Acute Intraocular InflammationJuly 1, 2026
  • Acute Multi-Organ DysfunctionJune 2, 2026
  • WHO Resource References Brighton Collaboration StandardsMay 11, 2026

Most Recent Posts

  • Brighton Collaboration News — Summer 2026August 31, 2026
  • Fetal VacciniaAugust 10, 2026
  • Acute Intraocular InflammationJuly 1, 2026

Posts

  • Brighton Collaboration News — Summer 2026
  • Fetal Vaccinia
  • Acute Intraocular Inflammation
  • Acute Multi-Organ Dysfunction
  • WHO Resource References Brighton Collaboration Standards
  • Request for Review: Acute Multi-Organ Dysfunction (aMOD) Brighton Case Definition
  • In Memory of Dr. William Foege
  • Brighton Collaboration News — December 2025
  • Request for Review: Acute Intraocular Inflammation Draft Brighton Case Definition
  • Standardized template with key considerations for a benefit/risk assessment for the emergent vesicular stomatitis virus (VSV) viral vector vaccine for Lassa fever
Download.pdf
Download.txt

Contact us for help?

Contact with us through our representative or submit a business inquiry online.

Contact Us

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

  • Case Definitions
  • Safety Templates
  • Covid-19
  • Trusted Sources
Linkedin

© Brighton Collaboration  2023. All rights reserved.

  • Disclaimer and Privacy Policy